XML 15 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Stockholders' Deficit - USD ($)
$ in Thousands
Total
Convertible Note Interest
The Mann Group L L C
Common Stock
Common Stock
Convertible Note Interest
The Mann Group L L C
Additional Paid-in Capital
Additional Paid-in Capital
Convertible Note Interest
The Mann Group L L C
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning Balance at Dec. 31, 2023 $ (246,168)   $ 2,700   $ 2,980,539     $ (3,229,407)
Beginning Balance (in shares) at Dec. 31, 2023     270,034,000          
Issuance of common stock from market price stock purchase plan 1,361       1,361      
Issuance of common stock from market price stock purchase plan (in shares)     416,000          
Net issuance of common stock associated with stock options and restricted stock units 266   $ 3   263      
Net issuance of common stock associated with stock options and restricted stock units (in shares)     337,000          
Issuance of common stock pursuant to conversion notes   $ 56       $ 56    
Issuance of common stock pursuant to conversion notes (in shares)       15,000        
Stock-based compensation expense 3,885       3,885      
Net Income (Loss) 10,630             10,630
Ending Balance at Mar. 31, 2024 (229,970)   $ 2,703   2,986,104     (3,218,777)
Ending Balance (in shares) at Mar. 31, 2024     270,802,000          
Beginning Balance at Dec. 31, 2023 (246,168)   $ 2,700   2,980,539     (3,229,407)
Beginning Balance (in shares) at Dec. 31, 2023     270,034,000          
Net Income (Loss) 20,166              
Ending Balance at Sep. 30, 2024 (209,926)   $ 2,753   2,995,974   $ 588 (3,209,241)
Ending Balance (in shares) at Sep. 30, 2024     275,775          
Beginning Balance at Mar. 31, 2024 (229,970)   $ 2,703   2,986,104     (3,218,777)
Beginning Balance (in shares) at Mar. 31, 2024     270,802,000          
Net issuance of common stock associated with stock options and restricted stock units (4,933)   $ 19   (4,952)      
Net issuance of common stock associated with stock options and restricted stock units (in shares)     1,855          
Issuance of common stock pursuant to conversion notes   $ 3,750   $ 15   $ 3,735    
Issuance of common stock pursuant to conversion notes (in shares)       1,500        
Issuance of common stock under the employee stock purchase plan 959   $ 3   956      
Issuance of common stock under the employee stock purchase plan (in shares)     310          
Stock-based compensation expense 6,428       6,428      
Net Income (Loss) (2,014)             (2,014)
Ending Balance at Jun. 30, 2024 (225,780)   $ 2,740   2,992,271     (3,220,791)
Ending Balance (in shares) at Jun. 30, 2024     274,467          
Net issuance of common stock associated with stock options and restricted stock units (1,511)   $ 13   (1,524)      
Net issuance of common stock associated with stock options and restricted stock units (in shares)     1,308          
Stock-based compensation expense 5,227       5,227      
Unrealized gain on available-for-sale securities 588           588  
Net Income (Loss) 11,550             11,550
Ending Balance at Sep. 30, 2024 (209,926)   $ 2,753   2,995,974   588 (3,209,241)
Ending Balance (in shares) at Sep. 30, 2024     275,775          
Beginning Balance at Dec. 31, 2024 (78,816)   $ 3,029   3,118,865   1,109 (3,201,819)
Beginning Balance (in shares) at Dec. 31, 2024     302,960,000          
Net issuance of common stock associated with stock options and restricted stock units 1,590   $ 10   1,580      
Net issuance of common stock associated with stock options and restricted stock units (in shares)     959,000          
Stock-based compensation expense 5,385       5,385      
Unrealized gain on available-for-sale securities 65           65  
Net Income (Loss) 13,158             13,158
Ending Balance at Mar. 31, 2025 (58,618)   $ 3,039   3,125,830   1,174 (3,188,661)
Ending Balance (in shares) at Mar. 31, 2025     303,919,000          
Beginning Balance at Dec. 31, 2024 (78,816)   $ 3,029   3,118,865   1,109 (3,201,819)
Beginning Balance (in shares) at Dec. 31, 2024     302,960,000          
Net Income (Loss) 21,811              
Ending Balance at Sep. 30, 2025 (44,552)   $ 3,070   3,132,249   137 (3,180,008)
Ending Balance (in shares) at Sep. 30, 2025     307,027          
Beginning Balance at Mar. 31, 2025 (58,618)   $ 3,039   3,125,830   1,174 (3,188,661)
Beginning Balance (in shares) at Mar. 31, 2025     303,919,000          
Issuance of common stock from market price stock purchase plan 337   $ 1   336      
Issuance of common stock from market price stock purchase plan (in shares)     74          
Net issuance of common stock associated with stock options and restricted stock units (5,983)   $ 20   (6,003)      
Net issuance of common stock associated with stock options and restricted stock units (in shares)     2,040          
Issuance of common stock under the employee stock purchase plan 951   $ 3   948      
Issuance of common stock under the employee stock purchase plan (in shares)     299          
Stock-based compensation expense 7,520       7,520      
Unrealized gain on available-for-sale securities 83           83  
Net Income (Loss) 668             668
Ending Balance at Jun. 30, 2025 (55,042)   $ 3,063   3,128,631   1,257 (3,187,993)
Ending Balance (in shares) at Jun. 30, 2025     306,332          
Issuance of common stock from market price stock purchase plan 50       50      
Issuance of common stock from market price stock purchase plan (in shares)     13          
Net issuance of common stock associated with stock options and restricted stock units (743)   $ 7   (750)      
Net issuance of common stock associated with stock options and restricted stock units (in shares)     682          
Adjustment for impairment loss of available-for-sale investment included in net income (1,269)           (1,269)  
Stock-based compensation expense 4,318       4,318      
Unrealized gain on available-for-sale securities 149           149  
Net Income (Loss) 7,985             7,985
Ending Balance at Sep. 30, 2025 $ (44,552)   $ 3,070   $ 3,132,249   $ 137 $ (3,180,008)
Ending Balance (in shares) at Sep. 30, 2025     307,027